This study was conducted to test the hypothesis that a Fab-based crota
lid antivenin (FabAV) in commercially packaged vials will remain effec
tive under more extreme heat and motion conditions than would be expec
ted in field settings. Vials containing FabAV were subjected to heat o
r motion. The effect of heat or motion on the ED50 Of FabAV was determ
ined using a mouse model of crotalid snake envenomation. The ED50 for
the heat stability groups (expressed as a ratio of mg antivenin to mg
venom) were as follows: 4 degrees Cx60 days (control) = 26.5, 70 degre
es C x 60 days = 66.3, 70 degrees C x 30 days = 52.4, 50 degrees C x 6
0 days = 25.8, 50 degrees C x 30 days = 34.0. The ED50 for the two mot
ion stability groups were similar: 4 degrees C x 60 days = 40.3 and 70
degrees C x 60 days = 48.3. These results indicate that FabAV is heat
stable at 50 degrees C for 60 days, but had less potency when heated
to 70 degrees C for 30 days. FabAV appears less potent after agitation
, but remains effective in the mouse model. We conclude that FabAV can
be safely stored for at least 60 days without refrigeration under mos
t field conditions where snake envenomation may occur. (C) 1998 Elsevi
er Science Ltd. All rights reserved.